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Abstract
Background: The Onchocerciasis Control Program (OCP) in West Africa has been closed down
at the end of 2002. All subsequent control will be transferred to the participating countries and will
almost entirely be based on periodic mass treatment with ivermectin. This makes the question
whether elimination of infection or eradication of onchocerciasis can be achieved using this strategy
of critical importance. This study was undertaken to explore this issue.
Methods: An empirical approach was adopted in which a comprehensive analysis was undertaken
of available data on the impact of more than a decade of ivermectin treatment on onchocerciasis
infection and transmission. Relevant entomological and epidemiological data from 14 river basins
in the OCP and one basin in Cameroon were reviewed. Areas were distinguished by frequency of
treatment (6-monthly or annually), endemicity level and additional control measures such as vector
control. Assessment of results were in terms of epidemiological and entomological parameters, and
as a measure of inputs, therapeutic and geographical coverage rates were used.
Results: In all of the river basins studied, ivermectin treatment sharply reduced prevalence and
intensity of infection. Significant transmission, however, is still ongoing in some basins after 10–12
years of ivermectin treatment. In other basins, transmission may have been interrupted, but this
needs to be confirmed by in-depth evaluations. In one mesoendemic basin, where 20 rounds of
four-monthly treatment reduced prevalence of infection to levels as low as 2–3%, there was
significant recrudescence of infection within a few years after interruption of treatment.
Conclusions: Ivermectin treatment has been very successful in eliminating onchocerciasis as a
public health problem. However, the results presented in this paper make it almost certain that
Published: 24 March 2003
Filaria Journal 2003, 2:8
Received: 27 September 2002
Accepted: 24 March 2003
This article is available from: http://www.filariajournal.com/content/2/1/8
© 2003 Borsboom et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
Page 2 of 25
(page number not for citation purposes)
repeated ivermectin mass treatment will not lead to the elimination of transmission of
onchocerciasis from West Africa. Data on 6-monthly treatments are not sufficient to draw
definitive conclusions.
Background
Ivermectin has been in operational use for more than a
decade, and the question of the required duration of treat-
ment is receiving renewed attention. In the ivermectin tri-
als that were undertaken over a decade ago, the
effectiveness of ivermectin treatment for morbidity con-
trol was demonstrated [1–3]. Transmission trials showed
that mass treatment with ivermectin resulted in a major
reduction in transmission of onchocerciasis in Africa [3].
However, after the first three rounds of treatment signifi-
cant transmission continued. Simulation models that
were calibrated using these early trial data predicted that
interruption of transmission by ivermectin treatment
alone would be difficult to achieve and that ivermectin
treatment needed to be planned for a period of decades
[4]. Hence, ivermectin treatment programs were estab-
lished with a long time frame in mind, with the exact du-
ration to be determined on the basis of further evaluation
of the long-term impact of mass treatment on transmis-
sion and the parasite reservoir.
With the closing down of the Onchocerciasis Control Pro-
gram (OCP) in West Africa at the end of 2002, all subse-
quent onchocerciasis control will be transferred to the
participating countries, and will almost entirely be based
on periodic mass treatment with ivermectin using the
strategy of Community Directed Treatment with Ivermec-
tin (CDTI) [5]. Questions still to be answered are where
this strategy should be implemented, at what frequency,
and for how long.
The question of the duration of treatment entails the ques-
tion whether elimination of transmission – or preferably
world wide eradication – with ivermectin treatment alone
is possible. If elimination of transmission in this way
turns out to be impossible, then, to avoid recrudescence,
control has to continue indefinitely or until alternative in-
terventions (e.g. macrofilaricidal drugs [6]) become avail-
able. Studies using the stochastic microsimulation
program ONCHOSIM [7], carried out by Winnen et al.
[4], indicate that prolonged high-coverage treatment pro-
grams with ivermectin would have a high probability of
achieving elimination. However, many uncertainties re-
main about these model predictions, and much effort is
needed to refine them. Therefore, at this moment, practi-
cal examples of successes of attempts to eliminate trans-
mission would be much more cogent arguments in favour
of the hypothesis that this is possible by using ivermectin
alone.
The question of the duration of ivermectin treatment pro-
grams was raised during the meetings of the Joint Program
Committee of the Onchocerciasis Control Program in
West Africa (OCP) and the Joint Action Forum of the Afri-
can Program for Onchocerciasis Control (APOC), held in
Yaounde, Cameroon, in December 2000. It was recog-
nised that the main experience with large-scale ivermectin
treatment sustained over a long period of time in Africa is
in the OCP. It was therefore recommended to undertake
an in-depth analysis of the relevant OCP data, and to use
the results of this to update ONCHOSIM model predic-
tions of the long term impact of ivermectin treatment on
onchocerciasis transmission, and of the feasibility to elim-
inate transmission of onchocerciasis with ivermectin
treatment alone. A detailed analysis plan was developed
during the annual internal operational research meeting
of the OCP in March 2001, and the Center for Decision
Sciences in Tropical Disease Control of the Erasmus Uni-
versity Rotterdam was contracted to undertake the analy-
sis and the corresponding ONCHOSIM simulations.
Results of the analysis were discussed during a meeting of
onchocerciasis experts, held from 3–5 October 2001 at the
Erasmus University Rotterdam, the Netherlands, and
sponsored by OCP and by the UNDP / World Bank /
WHO Special Program for Research and Training in Trop-
ical Diseases (TDR). In this paper, these results are report-
ed. The second phase of the work involved a recalibration
of the ONCHOSIM model on the basis of the observed
epidemiological trends in the different river basins select-
ed for analysis. This work will be reported separately. The
objectives of this study were:
1. to describe in detail the impact of ivermectin on epide-
miological and entomological parameters: prevalence of
microfilariae (mf), Community Microfilarial Load (CM-
FL), Annual Biting Rate (ABR), and Annual Transmission
Potential (ATP), and
2. to assess the potential to eliminate transmission of on-
chocerciasis by ivermectin treatment alone, and under
which conditions this can be achieved.
The same questions and answers are relevant for most of
the rest of Africa where onchocerciasis is endemic (APOC
countries), keeping in mind the absence of vector control
in APOC countries. As yet, eradication is not the objective
of APOC but evidence that ivermectin mass treatment
could lead to eradication might impact on its objectivesFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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and strategies. Thus, the conclusions drawn in this paper
may equally apply to APOC.
Materials and methods
Data
A total of 15 study areas were included in this study. 14
River basins / foci from the countries participating in the
OCP were selected on the basis of their history of ivermec-
tin treatment. These areas were divided into three groups,
depending on the control measures taken: 1) areas that
had ivermectin treatment only, 2) areas that had ivermec-
tin treatment and vector control in parallel, and 3) areas
that had ivermectin treatment after vector control. Areas
which only had larviciding done or were under ivermectin
treatment for too short a time, were excluded. Variation in
the epidemiological background and treatment history
were also important in selecting these areas. Data from the
following 14 river basins / foci were included in the
analysis:
1. Ivermectin treatment only:
A. River Gambia, Mako focus, Senegal and Guinea. 6-
Monthly ivermectin treatment since 1989.
B. Rio Corubal, Guinea Bissau. 3-Monthly ivermectin
treatment from 1991 until 1996.
C. Rio Gêba, Guinea Bissau. 6-Monthly ivermectin treat-
ment from 1989 until 1996.
D. Falémé, Senegal and Mali. Annual ivermectin treat-
ment since 1989.
E. Bafing, Mali and Guinea. Annual ivermectin treatment
since 1989.
F. Bakoye, Mali and Guinea. Annual ivermectin treatment
since 1989.
G. Baoulé, Mali. Annual ivermectin treatment since 1989.
2. Ivermectin treatment and (incomplete) vector control:
H. Tienfala focus, Mali. Annual ivermectin treatment since
1987 and (ground) larviciding since 1994.
I. Bui Gorge focus, Ghana. Annual ivermectin treatment
since 1987, 3-monthly ivermectin treatment from 1994–
1996, and aerial larviciding from 1975–1996.
J. Titira and Kouporgou focus, Togo. Annual ivermectin
treatment since 1988, and larviciding since 1977.
K. Milo and Sankarani, Guinea. Annual ivermectin treat-
ment since 1989, and aerial larviciding since 1989.
L. Asubende focus, Ghana. Annual ivermectin treatment
since 1987, and larviciding since 1990.
M. Dienkoa, Burkina Faso. Annual ivermectin treatment
since 1988, aerial larviciding since 1975 with some inter-
ruptions, ground larviciding since 1990.
3. Ivermectin treatment after vector control:
N. Bougouriba, Burkina Faso. 4-Monthly ivermectin treat-
ment since 1996, larviciding from 1975–1990.
In addition, one non-OCP study area was included, name-
ly Vina Valley in Cameroon. This was an area in which
only ivermectin treatment was used. In Figure 1, a map is
shown of the geographical locations of the 14 OCP areas.
All geographical, epidemiological, and entomological
data obtained between 1975 and 2001 were taken from
the OCP databases as available in February 2002. Analyses
of trends over time were made of the following epidemio-
logical and entomological variables:
1. The sex and age standardized prevalence of microfilari-
ae (mf) in people aged five years and older, directly stand-
ardized using the OCP standard population [8]. This
variable indicates the percentage of individuals with posi-
tive skin snip on either one of the two iliac crests,
2. The community microfilarial load (CMFL), calculated
as the geometric mean of the number of microfilariae per
skin snip in adults 20 years and older [9]. As this index in-
cludes those with a mf count of zero, the mean was calcu-
lated after a log(n  + 1) transformation, where n  = the
number of mf/snip. The CMFL is an indicator of the inten-
sity of infection in a community.
3. The annual biting rate (ABR); the estimated number of
Simulium bites a subject at a catching point would receive
per year. This index is presumably not affected by ivermec-
tin treatment, but is an indicator of human exposure to
Simulium fly bites.
4. The crude annual transmission potential (ATP); the es-
timated number of Onchocercal L3 larvae which would
have been transmitted to a subject at a catching site per
year. The crude ATP includes all Onchocerca species. It is
an indicator of human exposure to infectious Simulium
bites, and therefore directly measures ongoing
transmission.
5. The O. volvulus specific annual transmission potential (ATPO. volv.); the ATP due to O. volvulus exclusively.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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In addition to data from OCP databases, use was made of
spreadsheets supplied by OCP that contained informa-
tion on CDTI geographical and therapeutic coverage. This
information was compiled by OCP from notebooks kept
by the Community Distributors, that was in several areas
cross-checked by independent (non-OCP) assessors as
well as by OCP Vector Control Unit field staff not directly
involved with ivermectin treatment. Therapeutic coverage
as used in the OCP is defined as the percentage of subjects
treated out of the total census population. The eligible
population consisted of all people older than 5 years, ex-
cluding pregnant women and those too ill to take treat-
ment. Geographic coverage was defined as the percentage
of communities in a district that received treatment out of
the total number of eligible communities in that district.
Methods
The 14 study areas were first drawn on a paper map by
hand and were subsequently transferred to a digital for-
mat appropriate for the geographic information system
MapInfo version 6 (Maplnfo Corporation, One Global
View, Troy, New York 12180–8399, USA), that was used
for all geographical manipulations. Villages and capture
points were selected using a geographical query in Ma-
plnfo. Essentially, a village or a capture point was selected
if its coordinates fell within one of the study areas. Conse-
quently, survey villages or capture points that were actual-
ly located in one of the study areas but of which the
coordinates were not known (missing values for the coor-
dinates in the OCP databases) were not included. Addi-
tional capture points were identified by taking all nearest
capture points of the selected villages, as specified in the
OCP databases. Thereby, nearest capture points that were
(just) outside one of the study areas could be included.
Figure 1
Map of the 14 study areas within the area covered by the OCP.
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This was done to strengthen the relationship between en-
tomological and epidemiological variables. As some study
areas bordered each other, nearest capture points could
exist that were also nearest capture points of one or more
villages in another adjacent area. Data from these capture
points were used in the plots for both study areas. Capture
points without associated entomological data were
omitted.
Some of the study areas had, because of their close geo-
graphical proximity, a similar geography. These basins
have been grouped together to ease presentation. The Rio
Corubal and the Rio Gêba are discussed in one section,
and so are the Falémé, Bafing, Bakoye, and Baoulé rivers.
Because identical treatment schedules were used in these
last four basins, and because epidemiological and ento-
mological results were similar, only data aggregated over
these last four basins are presented.
The analyses were done using SPSS version 10 (SPSS Inc.,
233 S. Wacker Drive, Chicago, Illinois 60606, USA) and
Splus version 2000 (Insightful Corporation, 1700 West-
lake Avenue North, Suite 500, Seattle, Washington 98109-
3044, USA). All plots were made with Splus 2000.
Results
In Table 1 the numbers of survey villages and capture
points in the fourteen study areas from the OCP are
shown. This table also includes the number of epidemio-
logical and entomological observations available for each
area, aggregated over villages, respective capture points. In
all selected areas there were more villages than capture
points, while in the total dataset from the whole area cov-
ered by OCP there was much more balance in this respect.
This probably relates to the relative absence of vector con-
trol from these foci. In the absence of vector control fewer
capture points are needed. In many areas, only small
numbers of entomological observations were available,
especially in the seven areas in which ivermectin treat-
ment was used exclusively. The numbers of villages, cap-
ture points, and observations were not available for Vina
Valley, Cameroon.
Ivermectin distribution only
River Gambia, Mako focus (A)
Background
This basin is situated completely in the savannah area in
the southeastern part of Senegal and the northeastern part
of Guinea (Figure 1). In the northwestern part of the fo-
cus, along the Niokolo river, there is a large national park
that extends to the north bank of the River Gambia. There
is important human migration from south to north, and
from south to west. Only savannah vectors are present,
mostly S. sirbanum. The area is entomologically relatively
isolated. However, as migration of flies follows the domi-
nant winds, and relates to the proximity of the river ba-
sins, immigrating flies may come from the Falémé in the
east during the Harmattan period. DNA probe identifica-
tion of onchocercal larvae from collected flies started in
1992. In identified samples, collected and preserved in the
period 1986–1992, 23% savannah strains of O. volvulus
and 77% non-O. volvulus parasites (mostly O. ochengi)
were found. Before onchocerciasis control, this was a
hypo-/mesoendemic area. Pre-control prevalence ranged
Table 1: Number of survey villages and capture points and the total number of epidemiological and entomological observations per area 
in the 14 study areas from the OCP
Area Villages Capture Points
# Vil. # Obs. #Pts. # Obs.
Ivermectin distribution only:
- River Gambia, Mako focus (A) 16 79 8 26
- Rio Corubal (B) 67 115 6 14
- Rio Gêba (C) 18 38 7 11
- Falémé (D), Bafing (E), Bakoye (F), Baoulé (G) 163 341 72 233
Ivermectin and incomplete vector control:
- Tienfala focus (H) 7 18 5 47
- Bui Gorge focus (I) 18 47 6 87
- Titira and Kouporgou focus (J) 19 59 25 278
Ivermectin and vector control in parallel:
- Milo and Sankarani (K) 46 170 37 267
- Asubende focus (L) 7 45 1 24
- Dienkoa (M) 25 52 15 151
Recrudescence control with ivermectin:
- Bougouriba (N) 48 111 6 50Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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between 60% and 80%, and pre-control CMFL values
were > 30 mf/s in only two survey villages (Figure 2). The
prevalences in this focus differed considerably from those
in the surrounding areas. From a transmission point of
view, the rest of Senegal should be taken into account.
Experimental larviciding was carried out in 1989 for 20
weeks during the rainy season. Large-scale ivermectin
treatment started in 1989, with a 6-monthly treatment
schedule. Entomological studies were carried out for only
two years in preparation of treatment. Too few data were
recorded during these studies to obtain confident
conclusions.
Trends
The prevalence of mf and CMFL declined dramatically to
very low values, although low prevalences seem to persist
in a few villages (Figure 2). This suggests that the parasite
reservoir is close to suppression. The entomological data
is very limited. The very large fluctuations in ABR values
around an overall average value of 16900 may have been
the result of random sampling error, or of year-to-year
fluctuations because of, for instance, rainfall. The small
number of ATP measurements indicated highly variable
values around the rather high mean value of 4300, aver-
aged over capture points and time. In addition to the data
presented in Figure 2 there is some recent pool screening
data wherein no infective flies have been detected, sug-
gesting that current ATP values may be close to zero. How-
ever, this data involved only 3000 flies, which may be too
few to decide whether transmission is really interrupted.
No ATPO. volv. measurements were available. Therapeutic
treatment coverage was high (around 80%). In a recent in-
dependent evaluation a geographic coverage of 100% was
reported. Therefore, coverage in this basin seems to have
been good.
Figure 2
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude annual transmission 
potential (ATP) against time in the River Gambia / Mako (A) study area. The thick grey lines at the top indicate the period over 
which ivermectin mass treatment was given. Note that the top two panels refer to survey villages, and the bottom two panels 
to capture points.
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Problems and comments
The results suggest that ivermectin treatment may have in-
terrupted transmission in this area. However, this needs to
be confirmed by more detailed entomological studies
with full dissection of flies. If interruption of transmission
is confirmed in these studies, it could be considered to
stop treatment after a few more years (when the preva-
lence in all villages has fallen close to zero), while still
keeping the surrounding areas under control, and observe
whether transmission remains interrupted.
Rio Corubal (B) and Rio Gêba (C)
Background
The Rio Corubal is situated on the border between Guinea
and Guinea Bissau (Figure 1), while the Rio Gêba is al-
most entirely within Guinea Bissau on the border with
Senegal (Figure 1). Both areas are close to the River Gam-
bia, Mako focus. Rio Corubal used to be a mesoendemic
area, while the Rio Gêba had a very low pre-control ende-
micity. Vector control has never been applied in these
areas, but some capturing and dissection was done for a
period of four years in Rio Corubal (1989–1992) and two
years in Rio Gêba (1989–1990). Only the savannah vector
species S. sirbanum is present. DNA probe examinations
of parasites in 46 infective flies from both basins for the
period 1993–2000 showed 6.5% O. volvulus and 93.5%
non-O. volvulus. In Rio Corubal, 3-monthly ivermectin
treatment started in 1991, but ended in 1996 because of
civil strife in the area. In Rio Gêba, 6-monthly ivermectin
treatment was started in 1989, and also stopped in 1996.
Trends in Rio Corubal
Pre-control prevalence in the Rio Corubal basin varied
from almost zero to 73% (Figure 3), and CMFL levels were
mostly < 30 mf/s. Prevalence showed a favourable trend,
and decreased in most villages to values close to zero in
Figure 3
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude annual transmission 
potential (ATP) against time in the Rio Corubal (B) study area. The thick grey lines at the top indicate the period over which 
ivermectin mass treatment was given. Note that the top two panels refer to survey villages, and the bottom two panels to cap-
ture points.
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1997 when ivermectin was no longer distributed. Howev-
er, recently collected data strongly suggests that at least in
some villages prevalence is increasing again from 0–12%
in 1997 to values between 12% and 36% in 2001. The
plot of CMFL values shows a large heterogeneity at the
start of the treatment program. Some villages were meso-
or even highly endemic, but the majority had rather low
values. After the start of ivermectin distribution CMFL di-
minished to values close to zero around 1997 and after.
Unfortunately, almost all entomological data pertains to
the early intervention period, and has, therefore, little
bearing on the current situation. Only one more recent
observation, made in the capture point in the village
Cabuca, was available. ABR was not extremely high, ex-
cepting a few high points observed in Cabuca, and seems
compatible with a mesoendemic situation. Crude ATP
either was not very high, except again at capture point
Cabuca. No ATPO. volv. values were available. In
entomological studies carried out in July 1997 and July
2001 at Cabuca, 1 fly infected with O. volvulus was found
among 1054 and 1030 dissected flies respectively. Raw in-
fectivity declined from 60.61 inf/1000 p (infective flies
per 1000 parous flies) in July 1989 to 6.92 inf/1000 p in
July 1997 and then increased again to 45.73 inf/1000 p in
July 2001 at Cabuca. Therapeutic coverage increased from
around 60% at the start of the program to good values
around 80% in 1996. No data on geographic coverage was
available.
Trends in Rio Gêba
At the start of the program, prevalences in the Rio Gêba
basin varied from almost zero to 28%, and CMFL values
were < 5 mf/s. These low values decreased further to val-
ues near zero in 1997 (Figure 4). In 2001, when the last
epidemiological data was collected, only zero prevalences
and CMFL values were observed. ABR (range 0–7393) and
ATP (range 0–245) were quite low, and consistent with
the epidemiological parameters. O. volvulus specific ATPO.
volv. measurements were not available. In entomological
studies carried out in July 1997 and July 2001 at Station
Medidora no flies infected with O. volvulus were found
among 38 and respectively 331 dissected flies. Raw infec-
tivity at that capture point declined from 37.74 inf/1000
p in July 1990 to 8.10 inf/1000 p in July 1997, and to 0.0
inf/1000 p in July 2001. ABR and ATP at Station Medidora
were 134 and 0 respectively in 2001 (Figure 4). Therapeu-
tic coverage, although available for only three villages, ap-
pears to have been good (80%). Geographic coverage is
not known.
Problems and comments
The reason for the high frequency treatment regimen in
these areas was that OCP wanted to study in an area that
was hypo- to mesoendemic whether it was possible to in-
terrupt transmission by supplying a large quantity of iver-
mectin at short intervals. This was feasible because at that
time OCP used mobile treatment. The favourable figures
on therapeutic coverage show that this treatment schedule
was totally acceptable to the population.
Trends in the Rio Corubal area seem similar to those in
the River Gambia focus, but later follow-up showed evi-
dence of significant recrudescence. After cessation of con-
trol, prevalence was low but increased in four years time
to a serious high level under a low level of transmission –
as deduced from the available entomological data. After
about 20 rounds of ivermectin treatment in a mesoen-
demic situation this presents a situation of concern.
If the criterion of CMFL values < 10 mf/s had been ap-
plied, the Rio Gêba basin should not have been included
in the program at all. Despite the limited data available, it
seems that in this area onchocerciasis is now eliminated.
It is unclear whether this is the result of ivermectin
treatment or whether onchocerciasis would have died out
by itself in this low endemic area.
Falémé (D), Bafing (E), Bakoye (F), and Baoulé (G)
Background
These basins are located across the borders between Mali,
Senegal, and Guinea in the western extension area of the
program (Figure 1). Because of their geographical similar-
ity and comparable control regimens, their epidemiologi-
cal and entomological data was aggregated and presented
in one series of plots (Figure 5). The Falémé, a tributary of
the Senegal, is situated on the border between Senegal and
Mali (Figure 1), and has a complex river system with many
tributaries. It was not a high prevalence area and only just
qualified for inclusion in the program. The Bafing basin is
situated in Mali and Guinea and had a medium pre-con-
trol endemicity. The Bakoye is also situated in Mali and
Guinea, on the eastern side of the Bafing basin (Figure 1).
Pre-control endemicity levels in this basin were very vari-
able. The Baoulé study area is situated entirely in Mali.
Pre-control endemicity levels indicated that this was a me-
soendemic focus. The lower parts of the Falémé, Bafing,
Bakoye, and Baoulé were medium risk areas for blindness,
as they were situated in a zone with little or no onchocer-
cal blindness. The middle part of the Bakoye was, in terms
of CMFL, a high risk area for blindness. Only savannah
vector species are present, mostly S. sirbanum (100% in
Falémé basin, 66.5% in Bafing, 85.6% in Bakoye, and
82.7% in Baoulé), complemented by small percentages of
S. damnosum s.s., S. dieguerense and S. squamosum. Annual
ivermectin treatment was introduced in these four basins
in 1989.
Trends in the Falémé basin
Pre-control prevalence in 1986/1987 ranged from 13% to
64% (Figure 5). Since then, there has been a good down-Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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ward trend towards values below 5% in 2001. Pre-control
CMFL values were mostly low (< 10 mf/s), with the excep-
tion of one or two villages. CMFL also had a favourable
downward trend reaching values close to 0 mf/s in 2001
(range 0.0–0.13). Therapeutic coverage was good (around
80%). Very high ABRs (40000–50000) were observed in
some places, but most capture points had much lower val-
ues. The median ABR over all capture points and over the
total period of follow-up amounted to 8070. ATP also was
high at some sites (over 7000), but low at most others
(median ATP over time and capture points was 366). In
2000, 21% savannah strain O. volvulus were found in DNA
probe identification of 14 parasites. No entomological
data are available after 1990.
Trends in the Bafing basin
Most villages had pre-control CMFL values < 23 mf/s (Fig-
ure 5), and prevalences ranged from 0.4% to 68% with an
average of 32%. Prevalence and CMFL had good trends
towards very low values in 2001 (< 9% for prevalence and
< 0.2 mf/s for CMFL). Therapeutic coverage data was avail-
able for only two villages, and these data indicate that
coverage might not have been good (20%-80%). The ABR
was not so high, and was typically < 10000, with a median
value over all capture points and over time of 4600. This
was lower than in the Falémé basin, although these two
basins were comparable in terms of prevalence. Entomo-
logical data was scarce after 1990. Extensive follow-up un-
til 2000 was available for only one capture point with an
ABR that rose slowly from 180 in 1990 to 6455 in 2001.
ATP was also not very high (< 1000 in most villages). The
recent not yet zero ATP and ATPO. volv. values (0–100) sug-
gest that there is still some transmission going on. In
2000, no O. volvulus savannah strain were found in DNA
probe identification of 9 parasites.
Figure 4
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude annual transmission 
potential (ATP) against time in the Rio Gêba (C) study area. The thick grey lines at the top indicate the period over which iver-
mectin mass treatment was given. Note that the top two panels refer to survey villages, and the bottom two panels to capture 
points.
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Trends in Bakoye basin
Pre-control prevalence in this basin ranged from 7% to
73%. The trends in prevalence were good (Figure 5), with
the exception of one village that had a prevalence of 35%
in 1998 after which follow-up ceased. CMFL values before
control ranged from values near 0 mf/s to 35 mf/s, that
subsequently dropped to very low values. One village,
that was not followed up, had a pre-control CMFL of 64.1
mf/s. Therapeutic coverage was – with values slightly
above 80% – very good. No entomological data was col-
lected after 1990, but the ABRs and ATPs collected before
that year were compatible with a mesoendemic situation.
Median ABR over the whole period of follow-up and over
all capture points was 12400; median ATP over the whole
period and capture points was 771. There were occasional
much higher ABR (> 40000) and ATP (> 4000) values.
12%  O. volvulus savannah strain were found in DNA
probe identification of 190 parasites in 2000.
Trends in the Baoulé basin
Pre-control prevalences in this area ranged from 32% to
63% (Figure 5). Prevalences decreased to values near 0%
in 2001 (range 0–4%). CMFL values before the start of
treatment were in the range of 0.3–32 mf/s, and decreased
to zero values in 2000 and 2001. Therapeutic coverage
was good (70–80%). No entomological data was collect-
ed after 1990 in this basin also. ABR seemed somewhat
lower than in the other basins in this group, but was oth-
erwise consistent with a mesoendemic situation. Overall
median ABR was 4275 (range 475–25700). ATP was low
with a median value over all capture points and over time
of 350. There was one considerably outlying capture point
among these data, with a much higher ATP (10271) and
ABR value (25705) in 1985. This point seems to have
been visited up to 1985 only. In 2000, 39% O. volvulus sa-
vannah strain were found using DNA probe identification
among 31 parasites.
Figure 5
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Falémé(D), Bafing (E), Bakoye (F), and Baoulé (G) 
study areas. The thick grey lines at the top indicate the period over which ivermectin mass treatment was given. Note that the 
top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. volv. values are denoted by the grey 
symbols in the plot for ATP.
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Problems and comments
Based on data collected in the 1960s and 1970s these four
basins were highly endemic and vector control was
planned for them. Subsequently, the whole area was bad-
ly affected by drought in the 1970s and the beginning of
the 1980s. When OCP carried out epidemiological sur-
veys before starting the western extension, endemicity ap-
peared to be much lower than expected, and especially the
blinding form of the disease had disappeared from the
north of the area. Now the period of drought is over, and
rainfall and river discharge have returned to normal val-
ues, the entomological parameters may resemble those of
the 1960s and 1970s.
Geographical coverage may not have been very good. Be-
cause these basins are far from urban centers and have
very bad roads making communication difficult, they are
difficult to treat. The figures from the external evaluations
may, therefore, be inaccurate.
From the point of view of morbidity control, the situation
in the whole area is good, and onchocerciasis is no longer
a public health problem. The latest epidemiological re-
sults are similar to those for the Gambia basin in spite of
the different treatment interval (annual vs. 6-monthly).
The lack of recent entomological data makes it impossible
to state whether transmission has been interrupted. Be-
cause prevalences are still close to 10% in some villages,
stopping ivermectin distribution is, however, not
indicated.
Vina Valley, Cameroon
Background
The river Vina runs from west to east in the center of Cam-
eroon close to the borders with Chad and the Central Af-
rican Republic. The north of Cameroon is a sudano-
savannah region and is amongst the most hyperendemic
foci of the blinding savannah type onchocerciasis. The
Vina du Nord Valley is located between the sudano-savan-
nah focus in the north and the grassland further south. In
the grassland, endemicity of human onchocerciasis is low,
despite very high fly biting intensities and quite high O.
volvulus transmission. This is probably due to cattle zoö-
prophylaxis and cross-protective immunity by O. ochengi
transmission [10].
The area along the river Vina is geographically isolated by
mountain ranges on the north and on the south. Follow-
ing the civil upraise in the year 1928, a new main road was
built along the valley, and the villagers in the study area
around Sora Mboum were moved from their traditional
settlements uphill on the mountains south of the river to-
wards this road. There are now 63 villages in the valley, al-
most all of which lie on the road that runs from west to
east roughly parallel to the river. It is likely that the human
population came into much closer contact with Simulium
vectors and onchocerciasis after they moved to the road.
Wherever the road approached the river closely, there was
a very high hyperendemicity, with CMFL's in excess of 200
or 300 mf/s. Substantial proportions of the villagers had
severe eye lesions (7.1% in Touboro, and 19% in Bonand-
inga [11]).
Transmission is effected mainly by S. damnosum s.s.. A
small proportion of flies belong to S. sirbanum and S. sq-
uamosum. Pre-control ABR increased from 24250 at the
upstream part of the river in the west to 47450 at the
downstream part in the east. Pre-control ATP also in-
creased in the downstream direction from 1055 to 4190.
Just over one half to about three quarters of the infective
larvae were O. volvulus. Annual ivermectin treatment was
started by the Centre Pasteur in 1987 in the most eastern
part of the area. This area was expanded twice in 1988 to
cover the whole basin. Since 1995 all of north Cameroon
has been treated with ivermectin under control of APOC.
The percentage of flies infected with O. volvulus L3 de-
creased from a pre-treatment level of 0.0171% in 1987–
1988 to about 0.004% in 1992–1993 and then increased
again to 0.007% in 1996–1998. The percentage of non-O.
volvulus (O. ochengi and O. ramachandrini) declined slight-
ly from 0.013% in 1987–1988 to 0.010% in 1992–1996
and then increased to 0.016% in 1996–1998. Thus, O.
ochengi actually increases over the whole period, presum-
ably as a result of the increasing number of herdsmen
coming into the area from the north, driven south by
drought.
Trends
CMFL in Sora Mboum, in the center of the area, dimin-
ished quickly from about 50 mf/s in 1987/1988, to 1 in
1996/1997 [12]. Sora Mboum was not the most highly
endemic village in the area. Prevalence decreased from
80% in 1987/1988 to just over 20% in 1996/1997. O. vol-
vulus ATP decreased from 1221 in 1987/1988 to values be-
tween 200 and 500 in the following years. Levels
fluctuated following the trend in ABR. A very low number
of 29 was reached in 2000, but then it went up again to >
293. ATP due to O. ochengi increased constantly, while
there was also an increase in ATP due to O. ramachandrini
from the warthog.
Ivermectin was distributed free of charge during the early
phase of treatment in this area, but later on a system of
partial cost-recovery was applied. Treatment coverage var-
ied between 42% and 76% in two evaluated villages along
the river [13], but was most likely much lower in the peo-
ple from nomadic tribes. Therapeutic coverage was thus
not very high. Geographic coverage on the other hand was
high because almost all the population lived in theFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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villages along the road. The only exceptions being the no-
madic herdsmen who stayed in the bush. No coverage
data is available after 1994, but it is likely that values have
remained approximately the same. Treatment is now car-
ried out by APOC.
Problems and comments
The main conclusion is that there was a significant de-
crease in transmission due to 12 years of ivermectin treat-
ment in this area but certainly no interruption. However,
the now increasing proportion of bloodmeals on cattle
and the predominance of O. ochengi in the ATP is sup-
posed to have an overall beneficial synergic effect on the
reduction of human onchocerciasis [10,12].
Ivermectin and vector control in parallel
Tienfala focus (H)
Background
This is a highly endemic area, situated in southern Mali on
the river Niger, just on the border of the original program
area and the western extension (Figure 1). The area has a
complex history of larviciding. Aerial larviciding started in
1977 in the dry season, but was suspended in the rainy
season because of very high river discharges (> 2000 m3/
sec). No larviciding was done from 1977 until 1985. From
1986 until 1993 aerial and ground treatment were used,
but there were also periods in which treatment was sus-
pended. From 1994 to the present only ground larviciding
(by boat) was used on the river Niger. The huge size of the
complex of breeding sites makes vector control extremely
difficult in this area. One of the objectives is to protect the
people on the riverbanks against nuisance. Transmission
is effected by S. sirbanum exclusively. In 2001, the percent-
ages of O. volvulus strain differed considerably between
sites: 5% in Tienfala, 12% in Faya, 23% in Dylamba, and
32% in Sanankoro (Fie). Annual ivermectin treatment
was started in 1987. In the early 1980's nodulectomies
were performed in one village in this area in connection
with research on the population dynamics of O. volvulus
[14] until this research was stopped.
Trends
The trend in prevalence was good with levels before the
start of ivermectin treatment varying from 11% to 80% in
1987 decreasing to values ≤ 3% in 2000 (Figure 6). The
trend in CMFL was similarly good, with pre-ivermectin
control levels ranging from 9 to 70 mf/s dropping to near
zero values reached around 1995. Therapeutic coverage
rose from 60% in 1988 to 80% in 1998. ABR was general-
ly high and very variable, and sometimes even exception-
ally high (ranging from 0 to > 80000). ATP was mostly
below 700 with a few exceptional years with higher val-
ues. ATPO. volv. values, available from 1994 onwards, were
generally much lower, and varied between 7 and 135. ATP
did not seem to decrease very much, which seems to be
consistent with the fact that this ATP contained such a
large percentage non-O. volvulus.
Problems and comments
The dramatic decline in parasite loads in this holoendem-
ic focus is illustrative of good morbidity control. It is un-
clear what the relative contributions of vector control and
ivermectin distribution have been. However, as the pat-
tern of decline in epidemiological parameters was similar
to that observed in basins where only ivermectin distribu-
tion was used, and as the main part of the improvement
seems to have occurred after the introduction of ivermec-
tin treatment, it seems plausible that the contribution of
ivermectin was dominant. Apart from this, it should be
noted that there might have been a contribution from the
nodulectomies carried out in one of the villages, but this
is unlikely to have been very important.
Bui Gorge focus (I)
Background
Bui Gorge is located in Ghana on the lower Black Volta
(Mouhoun) river (Figure 1). This area has the largest con-
tinuous string of breeding sites in the program running
from Tagadi in the north to Tain-Aboi in the south. The
southern limit of the focus is not clearly defined. Most of
the flies in this area are savannah flies (S. damnosum s.s.
and S. sirbanum). Aerial larvidicing started in 1975 and
was stopped 22 years later on December 31, 1996. Some
nodulectomies were performed in a few places, but this
did not seem to have had much effect. Annual ivermectin
treatment was started in 1987. A 3-monthly treatment
schedule was used from 1994 to 1996.
Trends
Real pre-control epidemiological parameters are not avail-
able. Prevalences dropped from around 60% in 1980 to
low, but certainly not zero, values in 2001 (Figure 7). In
one village, a very high prevalence was observed in 1997.
After 1996, CMFL values were not high, indicating that 22
years of larviciding might have had an effect. Therapeutic
coverage was initially not good (50% in 1987) but was
much improved after 1995 (> 80% in 1997). ABR was very
variable and decreased from values in the range 7430–
26400 in 1975 to rather low values in the period 1980–
1985 but then increased again to be in the range 5202–
39850 in 1995 and later with an occasional extremely
high value (> 50000). ATP was high in some sites but not
in others and dropped to low levels around 1996. AT-
PO.volv. measurements, available for 1994 and later, were
similar to the crude ATP values.
Problems and comments
It is difficult to link entomological and epidemiological
data in this area. The most recent entomological data from
1996 suggest that transmission is very low or even absent,Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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while the epidemiological data from 1996 and later indi-
cate that transmission is still on-going. There may be sev-
eral explanations for this discrepancy. The first is human
migration. Sociological studies indicated that there was a
certain amount of population movement to the south. In
the south-eastern part there was still some amount of
transmission and treatment. Because of the low ATP levels
and high prevalences ivermectin treatment was intro-
duced. A second explanation might be that at Bui Dam
Site there is a population of fishermen who came from the
south where not all areas are treated.
The Ghanian government has planned to build a dam at
Bui-Damsite. The lake that will result from this project
will flood a lot of upstream breeding sites, which will
probably solve most of the problems in this area.
The situation in this basin is complicated by many factors.
Although larviciding had an effect, 22 years of vector con-
trol did not interrupt transmission. Ivermectin distribu-
tion has improved the epidemiological parameters but
has equally not interrupted transmission.
Titira and Kouporgou focus (J)
Background
This is a meso- to hyperendemic area located in the east-
ern part of the program in Togo (Figure 1). It is a moun-
tainous area with many huge breeding sites in the rainy
season. The core area consists of the Oti, Keran, Kara, and
Mo river basins. The Keran river runs through Togo and
Benin. Most of the flies are of the savannah species; there
are very few forest flies. It is likely that there is migration
of Simulium flies from the Oti to the Keran rivers. There is
much human migration in this area. Thousands of gold
miners migrate during the dry season from Ghana, Togo,
Figure 6
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Tienfala (H) study area. The thick grey lines at the 
top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period of vector 
control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. volv. values 
are denoted by the grey symbols in the plot for ATP.
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Benin, and Nigeria to the Keran river. It is also possible
that there are migrants from the south of Togo.
Larviciding started in 1977, but results were poor until in
1987 larviciding was started in the south. Annual ivermec-
tin distribution started in 1988. Aerial treatment was sus-
pended from 1993 until 1996 on the Oti, and on the
lower Keran and lower Kara rivers.
In 1997, the situation in this area became very problemat-
ic when larviciding appeared to be ineffective. In Titira, af-
ter 20 years of vector control, ATP was still about 400. This
lead some participants of the expert advisory committee
meeting of 1998 to believe it was better to stop. The rec-
ommendations that were made were to continue
larviciding and to increase, if possible, first the coverage of
larviciding and then the coverage of the ivermectin distri-
bution. These recommendations were strictly followed
and this has led to improvement. However, the situation
in this focus is still far from elimination of transmission.
Trends
Prevalence decreased from very high values (between 53%
and 89%) in 1977 to still high values (range 0–47%) in
2000 (Figure 8). CMFL has declined substantially from
values around 25 mf/s to very low values, but is in some
places not yet zero. Therapeutic coverage was reported to
be good (80%) with equally high geographic coverage
(96%). ABR has risen considerably in recent years to val-
ues around 15000, but this observation was based on data
from two capture points only, which had high values
throughout the whole period. ATP decreased from values
around 1000 at some catching points to much lower val-
ues, but remained above 100. Only in the last two years
may there have been an improvement in ATP towards val-
ues below 100. Similar trends were observed in the ATPO.
Figure 7
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO.volv.) against time in the Bui Gorge (I) study area. The thick grey lines at the 
top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period of vector 
control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO.volv. values 
are denoted by the grey symbols in the plot for ATP.
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volv. measurements, although on a somewhat lower level.
It is unclear as to what extent this improvement is attrib-
utable to vector control or to ivermectin treatment.
Problems and comments
It is clear that there are still problems in this area. The ep-
idemiological results are far from satisfactory, and signifi-
cant transmission continues. Recent CMFL values are low,
but the prevalences are still 0% to 47%. The entomologi-
cal data suggests that there has been improvement in the
last two years, but this is over a very short period only.
There may be several explanations for this. One is that
there is somehow a coverage problem with the ivermectin
distribution, despite that this is not confirmed by the in-
dependent evaluations. It should be noted that these last
evaluations were made in static villages only and did not
include the migrants, many of which (gold miners) are ex-
traordinarily hard to reach. Furthermore, ivermectin
distribution is difficult in this mountainous area with bad
roads and villages that are consequently difficult to reach.
This casts doubt on whether geographic coverage was re-
ally good enough. A further explanation may be that there
is transmission of disease going on in groups that do not
partake in the epidemiological monitoring (the taking of
skin snips), but there are no data to substantiate this. A
good coverage and reinvasion affecting the vectors could
also explain the situation. Finally, parasites could have
been brought in by migrants, but there is also no data that
supports this. In all, the epidemiological and entomolog-
ical data seem consistent. It is not possible to stop iver-
mectin distribution in this basin.
Figure 8
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Titira and Kouporgou (J) study area. The thick grey 
lines at the top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period 
of vector control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. 
volv. values are denoted by the grey symbols in the plot for ATP.
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Milo and Sankarani (K)
Background
The Milo and Sankarani are both tributaries of the Niger
river and belong to the intermediate zone between forest
and savannah. This zone is characterized by an intense
seasonal migration of forest and savannah flies from the
south-west to the north-east and vice versa with the help
of the monsoon and harmattan winds. A compilation of
weekly fly captures from 1988 to 1999 yielded that the
highest fly densities occur during the harmattan period
(the dry period including January, February, and March).
Furthermore, the maximum numbers of infective female
flies are found in this period of the year.
The Milo river is situated entirely in Guinea (Figure 1).
The Sankarani is almost entirely located in the eastern part
of Guinea; a small part extends to Cote d'lvoire. There is
sudano-guinean savannah in the medium and lower parts
of the basins. The lower parts are mountainous with more
vegetation. Maximum river discharge is in September and
October. The human populations are involved in agro-
pastoral activities and fishing. Other important activities
are diamond and gold mining, mainly done during the
dry season.
In the lower part of the Milo basin there is a predomi-
nance of savannah vectors (S. sirbanum and S. damnosum
s.s.) throughout the year. In the medium part, there is a
predominance of savannah vectors (S. sirbanum and S.
damnosum s.s.) during the dry season, and forest vectors
(S. squamosum essentially) in the rainy season. In the up-
per part of the basin, there is a predominance of forest vec-
tors (S. squamosum and S. yahense) throughout the year.
The proportions of parasite strains found in 35 infective
flies from 1993 to 2000 were 52% O. volvulus savannah,
14% O. volvulus forest, 32% non-O. volvulus. The pre-con-
trol situation in the Milo basin was hypo- to
hyperendemic with prevalences ranging from 4.4% to
87% in villages evaluated from 1985 to 1987 (Figure 9).
Anti-reinvasion larviciding was done in 1987 and 1988,
and full-scale larviciding was started in 1989. Large scale
annual ivermectin treatment started in 1989.
In the lower part of the Sankarani basin there is a predom-
inance of savannah vectors (S. sirbanum and S. damnosum
s.s.) throughout the year. In the medium and upper parts,
there is a predominance of savannah vectors (S. sirbanum
and S. damnosum s.s.) during the dry season and forest
vectors (S. squamosum) during the rainy season. The pro-
portions of parasite strains found in 36 infective flies col-
lected between 1993 to 2000 were 47% O. volvulus
savannah strain, 11% O. volvulus forest strain, and 42%
non-O. volvulus strain. Pre-control endemicity levels indi-
cated that this was a meso- to hyperendemic area with
prevalences varying from 26% to 88% in villages
evaluated between 1985 and 1987 (Figure 9). Anti-reinva-
sion and experimental larviciding were done in 1984 and
1988. Full-scale larviciding started in 1989. Large scale an-
nual ivermectin treatment also started in 1989.
Trends
There were favourable trends in the epidemiological data.
Prevalence dropped from very high values around 80% in
1985 to values < 10% but not yet zero in 2001 (Figure 9).
There was a similar trend in CMFL, that diminished from
very high values in some places (around 70 mf/s) to val-
ues near zero. This had occurred already in many villages
from 1993 onwards. There was an enormous pre-control
heterogeneity in CMFL values ranging from 1.3 mf/s to 69
mf/s. Therapeutic coverage decreased from 75% in 1989
to around 20% in 1997, which can be explained by the
fact that only those with a positive skin snip were treated.
There seems to be no information on geographical cover-
age. ABR was generally very high and increased slowly
from an average of 5430 in 1984, to an average of 13900
in 2001, with extremely high values (> 50000) occurring
occasionally at some sites. These high values may be the
result of reinvasion or of treatment failures. The rise in
ABR values may be partially explained by the suspension
of larviciding in the northern part of the OCP. ATP and
ATPO. volv. values were more favourable, and decreased
from values between 89 and 1930 in 1984 to values with-
in the range 0–120 in 2001.
Problems and comments
Good trends were observed in the epidemiological data
from these two basins. The entomological data seem con-
sistent with this, despite the high ABRs in some places.
The only logical conclusion seems to be that this
favourable situation is the result of the additional effect of
ivermectin treatment. To allow OCP to test whether the
strategy of 12 years of combined vector control and iver-
mectin treatment is indeed sufficient to eliminate the risk
of transmission it might be considered to stop vector con-
trol in a good basin and implement very close
monitoring.
Asubende focus (L)
Background
This is a hyperendemic focus located in the eastern part of
the southern extension on the Pru river in Ghana (Figure
1). The focus consists of a continuous string of breeding
sites along the river with the village Asubende in the cent-
er. From 1994 until 2000 almost all flies caught were of
the savannah strain; less than 1% were forest flies. In the
period January 1993 until December 2000 the propor-
tions of flies infected with the various parasite strains
were: 48% O. volvulus savannah, 20% O. volvulus forest,
and 32% non-O. volvulus. Vector control in the southern
extension was started in 1988. On the Pru it was suspend-Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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ed during the rainy seasons in 1988 and 1989 because of
xenodiagnostic studies, and because of studies of the
impact of ivermectin on transmission. Normal vector con-
trol has been done on the lower part of the Pru river since
1990. Annual ivermectin treatment was started in 1987.
Trends
There were favourable trends in the epidemiological data
(Figure 10). Prevalence decreased from values slightly
under 90% in 1987 to values below 5% at the end of
2000. CMFL declined from very high values, slightly over
70 mf/s in one village in 1987, to near zero values in
2000. Therapeutic coverage was high (around 70%). In a
recent evaluation, a geographic coverage of 80% was
found, and a therapeutic coverage of 76%. Thus, geo-
graphic coverage was good in Asubende, although it was
poor in Ghana as a whole. The ABR was high and very var-
iable over the years with maximum values above 40000 in
1978 and 1999, and minimum values between 3000 and
7500 in 1983, 1986 and in the period 1991–1994. ATP
dropped from values above 3000 in 1978 to values
around 200 in about 1991, and remained at that level
until 2001. When they became available, ATPO. volv. meas-
urements were almost equal to the ATP values, but were
substantially lower in more recent years.
Problems and comments
Despite the fact that the Asubende focus is a relatively
small area where much research has been done, the situa-
tion in this basin is unclear and complicated by many
factors.
Figure 9
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Milo and Sankarani (K) study area. The thick grey 
lines at the top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period 
of vector control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. 
volv. values are denoted by the grey symbols in the plot for ATP.
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First, there may be problems with the borders. No larvi-
ciding was done in the area to the south and on the upper
stream where before 1988 mostly forest flies were found.
Entomological studies indicated, however, that there was
little impact from immigrating vectors.
A second point concerns human migration and the result-
ing composition of the population. In December 2001, a
sociodemographic study was conducted on the Pru river.
One of the findings of this study was that the Pru basin in-
habitants are clustered in eleven villages along the bank of
the river. Many of the settlers are either indigenous to the
area, economic migrants or refugees (deprived popula-
tion) from the northern ethnic conflict. Other people
came from Volta, Upper West, Ashanti, or Brong Ahafo re-
gions [15].
A further important issue concerns the effectiveness of
vector control in this area. Current biting rates are similar
to pre-control values. Thus, vectors abound, and, as
indicated by the entomological data, there is still signifi-
cant transmission.
Finally, the change from mobile treatment to CDTI in
1996 turned out to be difficult to implement in Ghana. In
1996, ivermectin treatment was late for various reasons,
and the villagers complained about it. At that time, Ghana
had the lowest coverage of all the countries. This present-
ed a situation of concern because Asubende was an impor-
tant area with a very high prevalence. Therefore, much
effort was expended in providing an extra treatment in a
form somewhat different from regular CDTI. Thereafter,
the area was normally treated with CDTI.
Figure 10
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Asubende (L) study area. The thick grey lines at the 
top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period of vector 
control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. volv. values 
are denoted by the grey symbols in the plot for ATP.
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The entomological data clearly indicate that significant
transmission continues. It is therefore impossible to cease
ivermectin treatment. The prevalence and parasite
population are declining nicely but slowly, which appears
to be consistent with significant transmission in addition
to treatment. It is difficult to determine the impact of iver-
mectin on transmission.
Dienkoa (M)
Background
This is a small but severely affected focus, located in the
southwestern part of Burkina Faso on the Dienkoa river
near the border with Mali (Figure 1). The basin is in the
sudano-guinean zone with perennial medium sized rivers
and savannah vector species. The area is very fertile and
characterised by numerous hamlets and intensive migra-
tion. The many cattle in the area result in some O. ochengi
strain among collected parasites. Data from before 1974
(not shown in the plots), when control started, indicated
that this was a hyperendemic focus with an ABR of more
than 9000, an ATP of 1200, a prevalence of 68%, a rather
low CMFL of 13.9 mf/s, and a blindness rate of 2.8%.
The area has a complex history of treatment and monitor-
ing. Aerial larviciding was started in 1975. Because it was
difficult to select good sites representative of the epidemi-
ological situation, the regularly visited capture points
were changed with time. The network was restructured in
1978/1979, when the number of capture points was re-
duced as a result of serious financial difficulties in the pro-
gram. Better sites were selected in 1985, 1986 and 1988,
and three of these were regularly visited from 1986 on-
wards. From 1979 to 1989, larviciding turned out to be
very difficult, and was carried out irregularly. This resulted
in a resumption of transmission, and also, in 1983 and
1985, in the detection of a number of newly infected chil-
dren. No larviciding was done in the period 1987–1988
because of studies on the impact of ivermectin on trans-
mission. Annual ivermectin distribution started in 1988
with mobile treatment, and was switched to Community
Based Treatment with Ivermectin (CBTI) in 1996, and fi-
nally to CDTI. Because of the poor results and new infec-
tions found, and because some capture points indicated
that transmission was still continuing, systematic and
widespread ground larviciding was started in 1990.
Ground larviciding was easy to implement and gave good
results, leading to better epidemiological results from
1994 to the present.
Trends
Over the whole period, prevalence diminished from rath-
er high values in 1975 (average 60%) to values near zero
in 2000 (Figure 11). CMFL was quite variable at the start,
ranging from 3 mf/s to just over 30 mf/s, and dropped to
values near zero around 1993, after which this level was
maintained. Therapeutic coverage was 50% at the start in
1988, rising to 85% in 2000. Geographic coverage was
poor at the start of treatment, (about 5 villages treated),
but improved gradually until over 60 villages were treated
from 1997-onwards, although with a serious relapse in
2000 (31 villages). ABR decreased from a average value of
3700 at the start of the program in 1974 to an average of
1750 at the start of 2001, with a sudden increase in 1986
when larviciding was stopped. When vector control was
resumed it diminished again, but in some places prob-
lems with high values remained. ATP followed the same
pattern, and was generally low during the period of vector
control, but in recent years values above 100 were ob-
served in some places. ATPO. volv. values appeared substan-
tially lower than ATP measurements, but was at least in
one capture point above 100.
Problems and comments
The situation in this basin is complex, involving many fac-
tors outside vector control and ivermectin treatment. The
area forms part of the large area in Burkina Faso that ben-
efited from good vector control. It seems likely therefore,
that if vector control hadn't been interrupted to investi-
gate the effect of ivermectin treatment, similar results
would have been obtained as in the other areas. Also, the
focus was not clearly defined, and was expanded by in-
cluding new villages when problems turned out to be larg-
er than previously thought. There is also much migration
in this area. Because the surrounding regions are free of
onchocerciasis, migration from within Burkina Faso
should not matter much, but the large number of people
recently driven out of Cote d'lvoire is important. Lastly,
there were the problems with the changes in capture
points, and with an initially poor geographic coverage
that improved after the introduction of CDTI. The impact
of ivermectin on transmission in this basin is, therefore,
difficult to ascertain.
Ivermectin treatment after vector control
Bougouriba (N)
Background
The Bougouriba is a tributary of the Mouhoun (Black
Volta), and is located in the southwestern part of Burkina
Faso, bordering Ghana (Figure 1). It is in the sudano-gui-
nean savannah zone with forest galleries. The area has
non-permanent medium sized rivers, taking into account
that, for a considerable part of the period studied here,
there was drought. A number of national parks are located
along the river. There was intensive migration across the
border with Cote d'lvoire. The savannah vector species is
predominant. Pre-control data (not shown in the plots)
collected before 1974 indicated a hyperendemic situation,
with a prevalence of 83.7% at some places, a CMFL of 98
mf/s, a blindness prevalence of 11.6%, an ABR of more
than 6000, and an ATP >600.Filaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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Regular larviciding was done on the main river and on im-
portant tributaries during the period 1975–1990. The cap-
ture points on the main river were established at the
beginning of the program in 1974 but were reduced in
1978. There were many difficulties in accessing the rivers.
Because of turmoil in the area, ground larviciding was im-
possible. Prospections during the rainy seasons were done
by helicopter to complement ground prospections during
the dry seasons. On some tributaries, and in particular on
the Naimo, larviciding stopped in 1987. There was a com-
plete cessation of larviciding in 1990, when the usual eval-
uation sites indicated good results or good trends in the
preceding two years.
In the period 1976–1991, there was an organised installa-
tion of populations in the basin by the government, in
particular in the Naimo area. These migrants modified the
environment and thereby created new artificial breeding
sites. This new situation was not recognized at the time
when it was decided to stop larviciding. In 1992, post-
control entomological data collected at Batie on the Bam-
bassou river, also a tributary of the Mouhoun (Black
Volta) and close to the Bougouriba, indicated a deteriorat-
ing situation. In 1994, newly infected children were found
with an incidence > 1.8% in some villages. Even in the ar-
eas where in 1991 a low infectivity rate (0.6%) was found,
an increase to 5.9% was observed in 1995. In 1996, after
this had been discovered, large scale ivermectin treatment
on a 4-monthly schedule was started in the Bougouriba
basin for the purpose of recrudescence control.
Some ground larviciding was done in 1997 and 1998 to
protect the population of a village close to the Naimo at
breeding sites that were created as a result of the activities
of this population. This larviciding was done by the villag-
Figure 11
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Dienkoa (M) study area. The thick grey lines at the 
top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period of vector 
control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. volv. values 
are denoted by the grey symbols in the plot for ATP.
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ers themselves with technical support of the national
team.
From 1991 until 1998, upward trends in infectivity rates,
calculated from flies caught during the rainy season, were
found at Nabere and Zambo. In Nabere, calculated
infectivity rates were 0.39 (1991), 1.25 (1996), 2.33
(1997), and 8.65 (1998); in Zambo these rates were 0.61
(1991), 5.22 and 2.94 (both in 1996), and 5.77 (1998).
The reasons for these poor results are unknown. In 2000,
the local population caught flies that were analysed using
poolscreening. This yielded zero values for infectivity rates
at both sites, which seemed to be good. However, these
numbers are not reliable as not many flies were received.
A new evaluation is planned in which enough flies will be
caught for a proper analysis.
Trends
Prevalences declined from a pre-control average of 80% to
low values in 1990, after which they rose again to values
around 20% in some villages in 1996 (Figure 12). In the
villages for which data was available after the start of iver-
mectin treatment, prevalence was below 10% again in
2001. CMFL diminished to low values in 1990 and then
stayed low with the exception of some newly included sur-
vey villages. Because of the frequent ivermectin treatment
schedule epidemiological examination was difficult, and
only limited follow-up was available after 1996. Thera-
peutic coverage was quite good (70–80%). Geographic
coverage left much to be desired, because it was not exact-
ly known how many villages were to be treated. Further-
more, after an initial strong effort to get a good coverage,
the number of villages treated dropped from around 180
per year to values below 100 per year after 1998. After ces-
Figure 12
Prevalence of microfilariae (mf), community microfilarial load (CMFL), annual biting rate (ABR), and crude and O. volvulus spe-
cific annual transmission potentials (ATP and ATPO. volv.) against time in the Bougouriba (N) study area. The thick grey lines at 
the top indicate the period over which ivermectin mass treatment was given, while thin black lines indicate the period of vector 
control. Note that the top two panels refer to survey villages, and the bottom two panels to capture points. ATPO. volv. values 
are denoted by the grey symbols in the plot for ATP.
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sation of vector control in 1990, ABR rose to very high lev-
els after 1995 ranging from 19900 to 69500, and ATP rose
to over 400 in one capture point in 1998. Trends in the
scarce ATPO. volv. measurements mimicked those in the
ATP. In one of the two capture points ATPO. volv. became
low in 1998, but in the other it rose to over 350.
Problems and comments
The Bougouriba is a very problematic area in which a
much faster post-vector control recrudescence has oc-
curred than was anticipated from model simulations.
Discussion
We have presented a detailed description and analysis of
trends in prevalence of mf, CMFL, ABR, and ATP observed
between 1975 and 2001 in 14 river basins from the area
covered by the OCP, and in an area from the north of
Cameroon, with a view to assess the impact of ivermectin
mass treatment on epidemiological and entomological
parameters, and to assess the potential of ivermectin treat-
ment for elimination of transmission of onchocerciasis in
West Africa.
If elimination of transmission is feasible and reasonably
cost-effective, it is worth attempting to pursue that objec-
tive. If it is not feasible, control should either continue in-
definitely or until other forms of treatment, more effective
towards elimination, become available. As has already
been mentioned in the introduction, simulation studies
using ONCHOSIM [7], carried out by Winnen et al., [4]
indicate that prolonged – often for several decades – high-
coverage treatment programs, especially based on 6-
monthly treatment intervals, have a high probability of
achieving elimination. Several uncertainties remain, how-
ever, about these simulation results. Firstly, it is question-
able whether such high coverage rates (in excess of 80% in
highly endemic foci) in all transmission foci would be
sustainable. Secondly, it was assumed in the simulations
that drug-resistance would not emerge. Thirdly, not all as-
pects of reality may have been adequately captured by the
assumptions underlying the simulations. For example,
vector properties (e.g. zoöphily) may have been misspec-
ified for some foci, or vector longevity may differ from
that specified in the model.
Therefore, we argued that empirical examples of successes
of attempts to eliminate transmission would be much
more cogent arguments in favour of the hypothesis that
elimination is possible by ivermectin treatment alone. For
example, if in a holoendemic focus, prolonged ivermectin
treatment has been sustained at high levels and has actu-
ally achieved (near) elimination this would constitute
strong evidence that transmission can be sufficiently inter-
rupted at practicable coverage levels, and that elimination
of transmission by means of ivermectin mass treatment
programs alone is possible. If, despite sustained high cov-
erage rates and adequate frequency, elimination of trans-
mission seems not in sight in any example of a highly
endemic focus, this may raise doubt about the feasibility
of elimination by ivermectin alone. Successes achieved in
mesoendemic areas are, of course, less informative. Elim-
ination of transmission may well be possible in mesoen-
demic areas, but difficult to attain in highly endemic foci.
The main results in the 15 areas studied for this report are
presented in Table 2, where the impact of ivermectin mass
treatment on four aspects of the disease problem have
been summarised for each basin. The first aspect is the im-
pact of ivermectin treatment on the intensity of infection
as measured by the Community Microfilarial Load (CM-
FL). The CMFL is an index of the public health importance
of the disease. Onchocerciasis is considered a public
health problem when the CMFL exceeds 5–10 mf/s. The
second aspect is the impact of ivermectin on the preva-
lence of infection. The third aspect concerns whether or
not ivermectin distribution has interrupted transmission.
The fourth and last aspect is whether elimination of the
parasite has been achieved to the extent that control can
be stopped without risk of renewed transmission.
As indicated in the third and fourth columns of Table 2,
evidence from all 15 study areas clearly shows that
ivermectin treatment has been uniformly successful in
controlling onchocerciasis as a public health problem.
CMFL values are everywhere (near) zero, and, in most ba-
sins, prevalence of infection is generally quite low.
Interruption of transmission is a more difficult issue. In
some areas transmission is certainly continuing after 10–
12 years of ivermectin treatment. Problems in these areas
relate to, amongst others, stopping treatment too early
(Rio Corubal), shortcomings in therapeutic and/or geo-
graphic treatment coverage (Vina Valley, Titira,
Bougouriba), human migration (Titira, Asubende,
Bougouriba), migration of flies (Asubende), or to over-
looking a number of problem spots (Bougouriba).
There are also a few areas where transmission may have
been interrupted. However, there are still many
uncertainties involved, and further monitoring and re-
search is required to remove all doubt.
An important point involves the third and fourth columns
of Table 2. Stopping ivermectin distribution when low
levels of infection (low CMFL values), and low, but not
yet zero, prevalences are attained may result in very seri-
ous problems. This is illustrated by the results from the
Rio Corubal area where the most recent data show a seri-
ous and unexpected recrudescence. Therefore, even if in-
terruption of transmission has been achieved for someFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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time, when the parasite reservoir is not entirely eliminat-
ed, it is unclear whether ivermectin treatment can be
stopped.
Interruption of transmission in an area should be reflect-
ed by low and declining levels of observed epidemiologi-
cal and entomological indices (prevalence of mf, CMFL,
ABR, ATP) [16]. Inconsistencies between these two types
of data may make it hard to draw definitive conclusions.
Therefore, the apparent discrepancies between epidemio-
logical and entomological variables observed in several
study areas, where low CMFL measurements are compati-
ble with an absence of transmission, while at the same
time moderately high (crude) ATP measurements indicate
transmission is going on, need explanation. A first possi-
ble explanation might be that there was a positive correla-
tion between participation in skin snipping and reception
of ivermectin treatment. Those who did not participate in
ivermectin treatment (and the data suggest that this may
concern a substantial number of persons) might have
been the same persons whose skin was never examined.
These individuals may act as a reservoir for continued
transmission that can better be ascertained from entomo-
logical than from epidemiological parameters. A second
possibility is that the entomological situation at the cap-
ture points was not very representative of the associated
survey villages. In this case, one should be aware of a pos-
sible bias in the data. In the presence of non-zero ATP val-
ues, one cannot conclude that transmission has been
interrupted, unless it is established that occasional reinva-
sion of infected flies accounts for the observed ATP, and
few individuals get reinfected by both male and female
parasites.
The third, and probably most plausible, explanation is
that the crude ATP, used in the graphs, includes transmis-
sion due to both human and animal parasite strains.
Therefore, this ATP may substantially overestimate ATP
due to O. volvulus strains alone, especially in areas with
many cattle and/or a highly zoöphilic behavior of the
flies. Vastly more detailed and important information on
transmission can be obtained now that recently devel-
oped PCR techniques permit the separate assessment of
ATP due to O. volvulus exclusively (ATPO. volv.), and ATP
due to O. ochengi from cattle. That crude ATP overesti-
mates O. volvulus specific ATP in at least some capture
points is illustrated in the plots by the ATPO. volv. values,
that are often significantly lower than the corresponding
ATP measurements. Unfortunately, ATPO. volv. measure-
ments were only available for a small percentage of the se-
lected capture points, mostly from areas with vector
control and ivermectin mass treatment in parallel, and
only for recent years.
Table 2: Impact of ivermectin distribution on four aspects of onchocerciasis infection and transmission.
River Basin Intervention Strategy Impact of ivermectin treatment (Status in 2001)
PH problem eliminated 
(CMFL= 0)
Prevalence of infection very 
low (< 10%)
Transmission interrupted 
(Rx ongoing)
Elimination (control 
ceased)
Ivermectin only:
- River Gambia focus (A) 6-Monthly ivm.1 since 1989 √√ ?–
- R. Corubal (B) (up to 1996) 3-Monthly ivm. 1991–1996 √√ ?–
- R. Corubal (B) (from 1996 onwards) No ivm. since 1996 ? Increasing prevalence Transmission ongoing –
- Rio Gêba (C) 6-Monthly ivm. since 1989 and 
no treatment since 1996
√√ ??
- Falémé (D), Bafing (E), Bakoye (F), 
Baoulé (G)
Annual ivm. since 1989 √√ ?–
- Vina Valley (Cameroon) Annual ivm. since 1987 √ Prev. mf ≈ 20% in 1999 Transmission ongoing –
Ivermectin + vector control:
- Tienfala focus (H) Annual ivm. since 1987, and 
(ground) larv.2 since 1994
√√ ?–
- Bui Gorge focus (I) Annual ivm. since 1987 (3-
monthly from 1994–1996), and 
larv. from 1975–1996
√ Prev. mf up to 55% in 
1998
?–
- Titira and Kouporgou focus (J) Annual ivm. since 1988, and larv. 
since 1977
√ Prev. mf up to 50% in 
1998
Transmission ongoing –
- Milo and Sankarani (K) Annual ivm. since 1989, and larv. 
since 1989
√√ √ –
- Asubende focus (L) Annual ivm. since 1987, and larv. 
since 1990
√√ Transmission ongoing –
- Dienkoa (M) Annual ivm. since 1988, and larv. 
since 1975 (with interruptions)
√√ √ –
Ivermectin treatment after vector control:
- Bougouriba (N) 4-Monthly ivm. since 1996, and 
larv. from 1975–1990
√√ Transmission ongoing –
1ivm.: ivermectin treatment 2larv.: larvicidingFilaria Journal 2003, 2 http://www.filariajournal.com/content/2/1/8
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Transmission on non-O. volvulus species is thought to in-
fluence intensity of infection in two ways. First, it reduces
the vectorial capacity of blackfly populations for O. volvu-
lus (zoöprophylaxis) [17]. And secondly, inoculation in
humans of infective filarial larvae of animal origin that
cannot in this way develop into adult worms is hypothe-
sized to provide some degree of cross-protective immuni-
ty acting against O. volvulus. This is particularly true for the
species O. ochengi from cattle, which is closely related to
O. volvulus, in situations where the ATP due to O. ochengi
is considerably higher than the ATP due to O. volvulus
[10,12]. In view of the available data, however, it seems
difficult to separate effects of zoöprophylaxis and cross-
protective immunity from those of ivermectin treatment.
Overall, therapeutic ivermectin treatment coverage (i.e.
the coverage in villages reached by the program) was quite
high. This is favourable, implying that communities have
a positive attitude towards it. On the other hand, geo-
graphical treatment coverages are a cause for concern.
These also appear to have been somewhat irregular, with
some rounds of treatment reaching much higher levels of
geographical coverage than others. How this all works out
in terms of effective treatment coverage is not easy to esti-
mate. One could define, for operational purposes, the 'ef-
fective ivermectin coverage' by the fraction of bites that
flies take from individuals 'covered' by ivermectin treat-
ment program, i.e. from persons who have taken ivermec-
tin less than a specified time ago. As ABRs of treated and
untreated villages are not well known, actual effective iver-
mectin coverage is not precisely estimable. However, it
may have been much lower than the therapeutic coverages
when important – high transmission – villages were not
covered. If effective coverage rates were much lower than
therapeutic coverage rates, then it is hard to draw definite
conclusions about the potential impact of ivermectin. Al-
so, the question of whether higher effective coverage rates
are attainable, and whether these would have led to a dif-
ferent conclusion, i.e. that these would indeed lead to
elimination of transmission, cannot be answered with cer-
tainty on the basis of available empirical data.
As regards the frequency of treatment, we note the follow-
ing. The Titira region had both (incomplete) vector con-
trol and ivermectin distribution (approximately once per
year). Yet, elimination of transmission seems to be a re-
mote prospect. ATPs of up to 411 have recently been ob-
served. This suggests that annual ivermectin treatments
(sometimes even in the presence of imperfect vector con-
trol) in highly endemic areas, as actually practised, does
not interrupt transmission, at least not quickly. If trans-
mission continues at reasonably high levels, then elimina-
tion of infection would be impossible. However, it is
unknown whether this intervention, if sustained for a
more prolonged period would succeed in eliminating
transmission.
As regards 6-monthly treatments, the Bougouriba focus
would be able to provide important information on con-
trolling recrudescence in formerly hyperendemic areas
[2]. We recommend that detailed studies of this area be
undertaken. Such studies should include, in addition to
epidemiological and entomological data, precise ivermec-
tin coverage levels and treatment histories per individual
for all individuals in all villages where transmission may
take place. This would make it possible to assess whether,
on the individual level, participation in the treatment pro-
gram is random over time, or whether there are groups of
individuals that participate always and groups that partic-
ipate seldom or never. If a group of the latter type exists, it
would form a serious threat for future reinfection, espe-
cially if it is geographically clustered.
A final point regarding the frequency of ivermectin distri-
bution is the following. As far as elimination of onchocer-
ciasis as a public health problem is concerned, annual
treatment has been very effective and there appears to be
no need for shorter treatment intervals. A question then is
whether annual treatment should be continued in this
form or whether less frequent treatment schedules should
be considered, because when interruption turns out to be
impossible, treatment should be maintained for a very
long time. Implementing other treatment schedules, and
especially less frequent ones, may have important opera-
tional consequences as well as implications for the devel-
opment of ivermectin resistance. This last issue should be
further investigated, e.g. by incorporating ivermectin re-
sistance in the ONCHOSIM simulation model.
Conclusions
Both actual observations and ONCHOSIM predictions [4]
indicate that control of onchocerciasis by annual or more
frequent ivermectin treatment is possible when sustained
sufficiently long. However, the results presented in this
paper make it almost certain that repeated ivermectin
mass treatment will not lead to the elimination of on-
chocerciasis from West Africa. This most likely implies
that treatment will have to be continued indefinitely,
which might ultimately result in development of ivermec-
tin resistance. The latter forms a strong argument in favour
of upgrading research for a macrofilaricide effective
against O. volvulus because it is imperative that, should re-
sistance develop, a second line treatment is available (not-
withstanding the urgent need for a macrofilaricide that is
safe enough to be used on a large scale under rural condi-
tions in tropical Africa). Furthermore, elimination of
transmission will be elusive if reinfection (by immigrating
infective flies or infected humans) takes place. A precon-
dition therefore appears to be a very wide geographicalPublish with BioMed Central    and   every 
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coverage. Yet, even if elimination of transmission appears
to be nearly impossible, annual ivermectin treatments can
lead to very low prevalence and CMFL values. The objec-
tive of eliminating onchocerciasis as a public health prob-
lem by annual ivermectin treatments – as long as it retains
its effectiveness – seems therefore feasible.
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